Cholesterol-lowering benefits of oat-containing cereal in Hispanic Americans

被引:79
作者
Karmally, W
Montez, MG
Palmas, W
Martinez, W
Branstetter, A
Ramakrishnan, R
Holleran, SF
Haffner, SM
Ginsberg, HN
机构
[1] Columbia Univ, Med Ctr, Irving Ctr Clin Res, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Med Epidemiol, San Antonio, TX 78285 USA
关键词
D O I
10.1016/j.jada.2005.03.006
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This randomized, controlled trial of cholesterol lowering by an oat bran cereal containing beta glucan vs a corn cereal without soluble fiber in Hispanic Americans was conducted for 11 weeks. One-hundred fifty-two men and women, ages 30 to 70 years, with baseline low-density lipoprotein cholesterol (LDL-C) levels between 120 and 190 mg/dL and triglycerides < 400 mg/dL were included. After eating a National Cholesterol Education Program Step 1 diet for 5 weeks, subjects were randomly assigned to the corn or the oat cereal for the next 6 weeks. The daily dose of beta glucan was 3 g. Consumption of oat cereal was associated with a reduction in plasma levels of both total cholesterol (-10.9 +/- 21.6 mg/dL; -4.5%) and LDL-C (-9.4 +/- 20.3 mg/dL; -5.3%). Consumption of corn cereal did not affect either total cholesterol (+1.2 +/- 18.3 mg/dL; 1.1%) or LDL-C (+1.2 +/- 17.5 mg/dL; 2.2%). Differences between the effects of the two cereals on total cholesterol and LDL-C were significant, P=.0003 and P=.0007, respectively.
引用
收藏
页码:967 / 970
页数:4
相关论文
共 16 条
[1]   Effect of an oat bran enriched diet on the atherogenic lipid profile in patients with an increased coronary heart disease risk -: A controlled randomized lifestyle intervention study [J].
Berg, A ;
König, D ;
Deibert, P ;
Grathwohl, D ;
Berg, A ;
Baumstark, MW ;
Franz, IW .
ANNALS OF NUTRITION AND METABOLISM, 2003, 47 (06) :306-311
[2]  
Brown L, 1999, AM J CLIN NUTR, V69, P30
[3]  
BURR ML, 1989, LANCET, V2, P757
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]  
HENDEE WR, 1991, JAMA-J AM MED ASSOC, V265, P248
[6]   Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial [J].
Jenkins, DJA ;
Kendall, CWC ;
Vuksan, V ;
Vidgen, E ;
Parker, T ;
Faulkner, D ;
Mehling, CC ;
Garsetti, M ;
Testolin, G ;
Cunnane, SC ;
Ryan, MA ;
Corey, PN .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (05) :834-839
[7]  
Johnston L., 1998, Nutrition in Clinical Care, V1, P6
[8]  
Kuczmarski M. F., 1995, Nutrition Today, V30, P30
[9]   DIET AND 20-YEAR MORTALITY FROM CORONARY HEART-DISEASE - THE IRELAND-BOSTON DIET HEART STUDY [J].
KUSHI, LH ;
LEW, RA ;
STARE, FJ ;
ELLISON, CR ;
ELLOZY, M ;
BOURKE, G ;
DALY, L ;
GRAHAM, I ;
HICKEY, N ;
MULCAHY, R ;
KEVANEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) :811-818
[10]   RISK-FACTORS FOR CARDIOVASCULAR MORTALITY IN MEXICAN-AMERICANS AND NON-HISPANIC WHITES - THE SAN-ANTONIO HEART-STUDY [J].
MITCHELL, BD ;
STERN, MP ;
HAFFNER, SM ;
HAZUDA, HP ;
PATTERSON, JK .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (03) :423-433